Macfos: Consolidated PAT Up 45% YoY to ₹7.35 Cr as Margins Recover From Q1 Dip
PAT +45.26% YoY · revenue +44.22% · margins expanding
₹98.73 Cr
+44.22% YoY
₹7.35 Cr
+45.26% YoY
7.39%
-0.5pp YoY
₹7.1
Macfos Ltd's consolidated revenue came in at ₹98.73 Cr for Q2 FY27, up 21.4% QoQ and 44.2% YoY, with consolidated PAT of ₹7.35 Cr, up 26.5% QoQ and 45.3% YoY; EPS was ₹7.10 against ₹5.61 in Q1 FY27. There were no exceptional items in either period, and standalone PAT of ₹7.36 Cr is within 1.2% of the consolidated number, so basis makes little practical difference this quarter — the two subsidiaries remain near-dormant. The YoY comparison here uses the Sept-2025 quarter as restated under the Ind AS framework the company adopted voluntarily from 1 April 2026 (₹68.45 Cr revenue, ₹5.06 Cr PAT); our own prior records carry a materially higher 'year-ago quarter' figure (₹127.72 Cr revenue) that lines up almost exactly with this filing's H1 FY26 cumulative total rather than the standalone Q2 FY26 quarter, so that older figure looks mislabeled and has not been used for the growth math above.
Q2 FY-2027 vs prior quarters
Operating margin (profit before tax adjusted for other income and finance cost, over revenue) recovered to roughly 11.8% in Q2 FY27 from about 9.6% in Q1 FY27 — Q1's own commentary had flagged margin softening as the company invested in scaling fulfilment and capability. Net margin held broadly steady near 7.4%. Employee benefit expenses rose 40.3% YoY to ₹4.31 Cr and finance costs rose 74.6% YoY to ₹1.50 Cr as the company kept hiring and borrowing to fund growth. That shows up directly on the balance sheet: consolidated inventory is up 45.7% since FY26-end to ₹115.94 Cr, and current borrowings have nearly doubled to ₹63.12 Cr from ₹35.38 Cr, against a cash balance of just ₹1.54 Cr.
The stock went into the print at ₹1,120, down 0% over the past month of trading.
Management did not provide specific quantitative guidance but expressed confidence in sustaining strong growth, driven by robust demand in the electronics market, which they see as remaining 'hot' for the next few years. The core strategic focus is on maintaining healthy margins through scale advantages and by growing
— This quarter: met
Management gave no quantitative FY27 target on its April 2026 concall, only qualitative confidence in sustaining strong growth in a market it called 'hot,' with margin support expected from the higher-margin 'Robu 2.0' proprietary-product initiative and explicit intent to fund inventory expansion through debt. This quarter's revenue growth, margin recovery and debt-funded inventory build track that framing directly, so the print reads as having met rather than beaten guidance, since no numeric bar was set. No management press release accompanied this specific filing to cross-check against, and no sell-side consensus estimate for this quarter turned up in search — Macfos carries no identified analyst coverage — so the result cannot be benchmarked against a street number this quarter.
W1
Whether operating margin holds near ~11.8% (Q2 FY27) or reverts toward the ~9.6% seen in Q1 FY27 as scale investment continues
W2
Debt-funded inventory build (₹115.94 Cr, +45.7% since FY26-end) against current borrowings of ₹63.12 Cr and cash of just ₹1.54 Cr — watch for working-capital strain if sales conversion lags
W3
Contribution of the 'Robu 2.0' proprietary product initiative, which management (April 2026) targeted for ~10 percentage points higher gross margin than the core business
Converted from ₹ Lacs; no exceptional items, no minority interest (subsidiaries Nuo Zhan Technologies and Macfos Electronics are near-dormant, ~₹12.4 Lakh combined assets, nil/negligible revenue); company voluntarily adopted Ind AS from 1-Apr-2026 and restated the Sept-2025 comparative down to ₹68.45 Cr revenue / ₹5.06 Cr PAT (consolidated) — this is materially different from our DB's stored 'year-ago quarter' figure (revenue ₹127.72 Cr, PAT ₹10.15 Cr), which closely matches this filing's H1 FY26 cumulative total rather than the single Q2 FY26 quarter and appears mislabeled upstream; YoY figures below use the filing's own restated quarterly column, not the DB figure.
Informational and educational content only. Not investment advice.